|
US6740682B2
(en)
|
1997-08-29 |
2004-05-25 |
Tularik Limited |
Meta-benzamidine derivatives as serine protease inhibitors
|
|
AU4166400A
(en)
*
|
1999-02-11 |
2000-08-29 |
Cor Therapeutics, Inc. |
Alkenyl and alkynyl compounds as inhibitors of factor xa
|
|
DE10012732A1
(de)
|
2000-03-18 |
2001-09-20 |
Aventis Behring Gmbh |
Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
|
|
SE0001803D0
(sv)
|
2000-05-16 |
2000-05-16 |
Astrazeneca Ab |
New compounds i
|
|
GB0108903D0
(en)
*
|
2000-10-05 |
2001-05-30 |
Aventis Pharm Prod Inc |
Novel crystalline forms of a factor Xa inhibitor
|
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
SK288217B6
(sk)
|
2001-01-26 |
2014-08-05 |
Merck Sharp & Dohme Corp. |
Zmes, terapeutická kombinácia, farmaceutický prostriedok a ich použitie
|
|
BRPI0206641B8
(pt)
|
2001-01-26 |
2021-05-25 |
Merck Sharp & Dohme |
uso de um inibidor da absorção de esteróis
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
US20020183519A1
(en)
*
|
2001-03-13 |
2002-12-05 |
Herbert Nar |
Antithrombotic carboxylic acid amides
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
DE60216300T2
(de)
|
2001-09-21 |
2007-06-28 |
Schering Corp. |
Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
|
|
GB0124934D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124939D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124941D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124931D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124933D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124938D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP1569912B1
(en)
|
2002-12-03 |
2015-04-29 |
Pharmacyclics, Inc. |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
|
|
KR101058292B1
(ko)
*
|
2002-02-12 |
2011-08-22 |
글락소스미스클라인 엘엘씨 |
Ｐ38 억제제로 유용한 니코틴아미드 유도체
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1394159A1
(fr)
*
|
2002-08-13 |
2004-03-03 |
Warner-Lambert Company LLC |
Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
AU2003291719A1
(en)
|
2002-11-06 |
2004-06-03 |
Schering Corporation |
Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
|
|
GB0230162D0
(en)
*
|
2002-12-24 |
2003-02-05 |
Metris Therapeutics Ltd |
Compounds useful in inhibiting angiogenesis
|
|
ES2311806T3
(es)
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
CN1756756A
(zh)
*
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
CA2517573C
(en)
*
|
2003-03-07 |
2011-12-06 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
EP1669348A4
(en)
*
|
2003-09-30 |
2009-03-11 |
Eisai R&D Man Co Ltd |
NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
|
|
GB0402143D0
(en)
*
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
JP2007531757A
(ja)
*
|
2004-03-30 |
2007-11-08 |
カイロン コーポレイション |
抗癌剤としての置換チオフェン誘導体
|
|
US20050241110A1
(en)
*
|
2004-04-09 |
2005-11-03 |
Bruce Baker |
Ergonomic handles, especially for garden tools
|
|
US7563780B1
(en)
*
|
2004-06-18 |
2009-07-21 |
Advanced Cardiovascular Systems, Inc. |
Heparin prodrugs and drug delivery stents formed therefrom
|
|
US20090227799A1
(en)
*
|
2004-08-09 |
2009-09-10 |
Kazutaka Nakamoto |
Novel Antimalarial Agent Containing Heterocyclic Compound
|
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
|
JP4874958B2
(ja)
|
2005-03-30 |
2012-02-15 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ピリジン誘導体を含有する抗真菌剤
|
|
GB0512429D0
(en)
*
|
2005-06-17 |
2005-07-27 |
Smithkline Beecham Corp |
Novel compound
|
|
TWI385169B
(zh)
*
|
2005-10-31 |
2013-02-11 |
Eisai R&D Man Co Ltd |
經雜環取代之吡啶衍生物及含有彼之抗真菌劑
|
|
ATE485264T1
(de)
*
|
2006-06-26 |
2010-11-15 |
Warner Chilcott Co Llc |
Prolylhydroxylase-hemmer und verfahren zu ihrer anwendung
|
|
US8183264B2
(en)
*
|
2006-09-21 |
2012-05-22 |
Eisai R&D Managment Co., Ltd. |
Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
|
|
TW200841879A
(en)
*
|
2007-04-27 |
2008-11-01 |
Eisai R&D Man Co Ltd |
Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
|
|
AU2008246798A1
(en)
*
|
2007-04-27 |
2008-11-13 |
Eisai R&D Management Co., Ltd. |
Salt of heterocycle-substituted pyridine derivative or crystal thereof
|
|
US8513287B2
(en)
|
2007-12-27 |
2013-08-20 |
Eisai R&D Management Co., Ltd. |
Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
|
|
US8188119B2
(en)
*
|
2008-10-24 |
2012-05-29 |
Eisai R&D Management Co., Ltd |
Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
|
|
GB0919194D0
(en)
|
2009-11-02 |
2009-12-16 |
Lytix Biopharma As |
Compounds
|
|
EP2496578A4
(en)
|
2009-11-05 |
2013-08-21 |
Univ Notre Dame Du Lac |
IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
|
|
AU2011229423B2
(en)
*
|
2010-03-18 |
2015-12-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anti-infective compounds
|
|
AU2012234323A1
(en)
|
2011-03-29 |
2013-10-17 |
Sanofi |
Otamixaban formulations with improved stability
|
|
PT2691371E
(pt)
*
|
2011-03-29 |
2015-07-20 |
Sanofi Sa |
Sal de ácido benzóico de otamixaban
|
|
WO2013014204A2
(en)
|
2011-07-26 |
2013-01-31 |
Sanofi |
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
|
|
EP2759533B1
(en)
|
2011-09-22 |
2017-08-02 |
Takeda Pharmaceutical Company Limited |
Condensed heterocyclic compound
|
|
AU2016324598A1
(en)
|
2015-09-17 |
2018-03-15 |
Marvin J. Miller |
Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
|